Trauma Resuscitation With Low-Titer Group O Whole Blood or Products

Status Recruiting

Clinical Trial Summary

The goal of this clinical trial is to compare the effectiveness of unseparated whole blood (referred to as Low-Titer Group O Whole Blood) and the separate components of whole blood (including red cells, plasma, platelets, and cryoprecipitate) in critically injured patients who require large-volume blood transfusions.

Clinical Trial Description

Trauma is one of the leading causes of death in the United States, and disproportionately affects the young, killing those who might otherwise have lived long and productive lives. Injuries account for more years of potential life lost before age 75 than any other cause. Hemorrhage remains the most common cause of preventable death after injury, and blood transfusion is an essential part of treatment. Modern blood banking practices separate donated whole blood into components. The current standard of care in trauma transfusion is the balanced administration of equal numbers of units of blood components (packed red blood cells, plasma, and platelets), effectively attempting to reconstitute whole blood. A renewed approach to blood transfusion therapy in trauma is to use whole blood from the outset, which has not been separated. Compared with component therapy, whole blood offers several potential advantages, but there are only a small number of, mostly observational, studies comparing whole blood and component therapy, and they are very heterogeneous. The TROOP trial will include injured adults with hemorrhagic shock anticipated to require massive blood transfusions, who will be randomized to receive either whole blood (LTOWB) or blood components. This will allow a direct comparison to see if one type of transfusion is more strongly associated with improved clinical outcomes over the other. The knowledge gained from this clinical trial will transform the way in which massively bleeding trauma patients are transfused. The trial is exceedingly well positioned to improve mortality from trauma and reduce the number of preventable deaths resulting from hemorrhagic shock. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05638581
Study type	Interventional
Source	University of Alabama at Birmingham
Contact	Shannon Stephens, EMTP, CCEMTP
Phone	205-934-5890
Email	swstephens@uabmc.edu
Status	Recruiting
Phase	Phase 3
Start date	July 27, 2023
Completion date	June 30, 2027

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04554212` - Blood Flow Restriction Training After Patellar INStability	N/A
Suspended	`NCT02932176` - Machine Learning for Handheld Vascular Studies
Recruiting	`NCT04803253` - Study of the Social and Professional Reintegration Improvements Using a Set of Solutions for Upper Limb Amputation	N/A
Completed	`NCT00116337` - Spinal Cord Stimulation to Restore Cough	N/A
Completed	`NCT03463720` - Outcome for Patients With War-Associated Extremity Wound Infection	N/A
Completed	`NCT03113253` - TRANexamic Acid to Reduce Bleeding in BURN Surgery	Phase 4
Not yet recruiting	`NCT05492903` - COMmunity of Practice And Safety Support for Navigating Pain (COMPASS-NP)	N/A
Terminated	`NCT02909231` - One-year Patient Reported Outcomes Following Hospitalization for Trauma	N/A
Completed	`NCT02432456` - Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients	Phase 4
Completed	`NCT02744144` - Wound Bacterial Microbiota and Their Antibiotic Resistance	N/A
Completed	`NCT02266771` - Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice	N/A
Completed	`NCT02394821` - Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide	Phase 3
Not yet recruiting	`NCT01665963` - Efficacy of TopClosure(C)System in Healing Complicated Pacemaker Wounds	N/A
Completed	`NCT00151112` - Comparison of Two Different Procedures for Plexus Anesthesia	N/A
Not yet recruiting	`NCT03872544` - Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Recruiting	`NCT04596124` - Effectiveness and Tolerability of Fitostimoline Plus Cream and Gauze vs Connettivina Bio Plus Cream and Gauze	N/A
Recruiting	`NCT05800834` - Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds	Phase 2
Enrolling by invitation	`NCT03880188` - Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Terminated	`NCT04775316` - Prospective, International, Multicenter, Observational Study to Evaluate the Clinical Performance and Safety of a Silicone-coated Transparent Postoperative Dressing
Enrolling by invitation	`NCT03312504` - Implementing a School Prevention Program to Reduce Injuries Through Neuromuscular Training	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Trauma Resuscitation With Low-Titer Group O Whole Blood or Products — TROOP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms